Hochschulschrift
Re-challenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
76 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Frankfurt (Main), Univ., Diss., 2012
- Klassifikation
-
Medizin, Gesundheit
- Schlagwort
-
-
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:15 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
(Neo)adjuvant approaches in lung cancer—paving the road to a cure
Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
(Neo)adjuvant approaches in lung cancer—paving the road to a cure
Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
(Neo)adjuvant approaches in lung cancer—paving the road to a cure